CDMO Delpharm gets cash infusion from Canada to help modernize former Sandoz injectables plant
Equipped with a 60-million-Canadian-dollar ($42 million) investment from the Canadian government, CDMO Delpharm is striking out on a multiyear campaign to modernize, upgrade and expand an injectables facility it bought from Sandoz in 2022. The plant, which supplies drugs locally and to the U.S., is among the largest for sterile injectables production in Canada.
Equipped with a 60-million-Canadian-dollar ($42 million) investment from the Canadian government, CDMO Delpharm is striking out on a multiyear campaign to modernize, upgrade and expand an injectables facility it bought from Sandoz in 2022. The plant, which supplies drugs locally and to the U.S., is among the largest for sterile injectables production in Canada.
